Clinical Trials Logo

Indobufen clinical trials

View clinical trials related to Indobufen.

Filter by:
  • None
  • Page 1

NCT ID: NCT03871517 Completed - Ischemic Stroke Clinical Trials

INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURE

Start date: June 3, 2019
Phase: Phase 4
Study type: Interventional

China has the largest burden of cerebrovascular disease in the world. About 60% to 80% of which are ischemic stroke. In recent years, stroke has replaced heart disease and tumor diseases as the first cause of death and disability in adult population. The primary purpose of this study is to evaluate the efficacy of indobufen treatment in reducing the risk of a 3-month new stroke (any type of stroke, including ischemic stroke and hemorrhagic stroke) for patients with moderate/severe ischemic stroke is not inferior to aspirin therapy.